Liu, YinSmith, Margaret R.Wang, YuezhuD’Agostino, Ralph, Jr.Ruiz, JimmyLycan, ThomasKucera, Gregory L.Miller, Lance D.Li, WenchengChan, Michael D.Farris, MichaelSu, JingSong, QianqianZhao, DawenChandrasekaran, ArvindXing, Fei2024-01-052024-01-052023-05-05Liu Y, Smith MR, Wang Y, et al. c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities. Cancers (Basel). 2023;15(9):2626. Published 2023 May 5. doi:10.3390/cancers15092626https://hdl.handle.net/1805/37635The brain is one of the most common metastatic sites among breast cancer patients, especially in those who have Her2-positive or triple-negative tumors. The brain microenvironment has been considered immune privileged, and the exact mechanisms of how immune cells in the brain microenvironment contribute to brain metastasis remain elusive. In this study, we found that neutrophils are recruited and influenced by c-Met high brain metastatic cells in the metastatic sites, and depletion of neutrophils significantly suppressed brain metastasis in animal models. Overexpression of c-Met in tumor cells enhances the secretion of a group of cytokines, including CXCL1/2, G-CSF, and GM-CSF, which play critical roles in neutrophil attraction, granulopoiesis, and homeostasis. Meanwhile, our transcriptomic analysis demonstrated that conditioned media from c-Met high cells significantly induced the secretion of lipocalin 2 (LCN2) from neutrophils, which in turn promotes the self-renewal of cancer stem cells. Our study unveiled the molecular and pathogenic mechanisms of how crosstalk between innate immune cells and tumor cells facilitates tumor progression in the brain, which provides novel therapeutic targets for treating brain metastasis.en-USAttribution 4.0 InternationalBrain metastasisBreast cancerc-MetLipocalin 2NeutrophilArticle